Item 7.01. Regulation FD Disclosure.

Lineage Cell Therapeutics, Inc. ("Lineage") will participate in virtual meetings with analysts and investors beginning January 6, 2021 and through the conclusion of the J.P. Morgan 39th Annual Healthcare Conference on January 14, 2021. During those meetings, Lineage will use a presentation handout, which is furnished as Exhibit 99.1 and is incorporated herein by reference. The presentation handout will also be made available in the "Investors" section of Lineage's website, located at investor.lineagecell.com.

Lineage undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time through the filing of other reports or documents with the Securities Exchange Commission, through press releases, or through other public disclosure, including in the "Investors" section of Lineage's website. Lineage routinely uses its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description
99.1            January 2021 corporate presentation handout
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses